Market revenue in 2022 | USD 5,187.6 million |
Market revenue in 2030 | USD 11,792.1 million |
Growth rate | 10.8% (CAGR from 2022 to 2030) |
Largest segment | Multivitamin |
Fastest growing segment | Vitamin D |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Multivitamin, Vitamin A, Vitamin B, Vitamin C, Vitamin D, Vitamin E, Vitamin K |
Key market players worldwide | Glanbia PLC, Pfizer Inc, Bayer AG, Amway Malaysia Holdings, GlaxoSmithKline, Nestle SA, NOW Foods, Abbott Laboratories, Herbalife Ltd, Natures Sunshine Products Inc, Nu Skin Enterprises Inc Class A, Pharmavite, Good Health, RBK Nutraceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vitamin supplements market will help companies and investors design strategic landscapes.
Multivitamin was the largest segment with a revenue share of 51.85% in 2022. Horizon Databook has segmented the China vitamin supplements market based on multivitamin, vitamin a, vitamin b, vitamin c, vitamin d, vitamin e, vitamin k covering the revenue growth of each sub-segment from 2017 to 2030.
Individuals in China have been increasingly focusing on their health in the past few years, which has boosted the demand for vitamin supplements in the country. The rising demand for these supplements can also be attributed to the diverse flavor options in the grab-n-go variety.
The government of China has taken numerous initiatives in recent years to promote the benefits of consuming healthy food and following a healthy lifestyle and also aims to raise the nutrient intake among consumers.
The "Healthy China 2030" initiative is a significant and comprehensive government program in China that outlines a strategic roadmap for developing the healthcare industry and improving public health for several years, specifically aiming to make substantial progress by 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the China vitamin supplements market , including forecasts for subscribers. This country databook contains high-level insights into China vitamin supplements market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account